HM15275

· Hanmi Pharmaceutical Company Limited

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for HM15275, covering 2025-05-22 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus [Phase 2]